Open, Ongoing and Recruiting Pediatric Neurology Studies

  • Randomized Study in Children and Adolescents With Migraine: Acute Treatment
    Study ID: NEU23013 (C4951002-BHV3000-311)
    PI: Wilson Heredia-Nunez. View Study Details

  • Focal Cerebral Arteriopathy Steroid Trial (FOCAS)
    Study ID: NEU23170 (FOCAS)
    PI: Anuj Jayakar. View Study Details

  • Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
    Study ID: NEU23134 (BT016)
    PI: Toba Niazi. View Study Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (EXPAND)
    Study ID: NEU23003 (N01269)
    PI: Anuj Jayakar. View Study Details

  • A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex (EpiCom)
    Study ID: NEU23103 (JZP926-402)
    PI: Paula Schleifer. View Study Details

  • Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects with AS (Aspire)
    Study ID: NEU24001 (GTX-102-CL301)
    PI: Paula Schleifer. View Study Details

  • Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
    Study ID: NEU99201 (NBI-98854-DCP3018)
    PI: Migvis Monduy. View Study Details

  • A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
    Study ID: NEU24007 (EP0224)
    PI: Anuj Jayakar. View Study Details